NLRP3 and metabolic dysfunction-associated steatotic liver disease: Upregulation of OGT enhances the stability and O-GlcNAcylation of NLRP3, thereby promoting inflammasome activation, lipid metabolism dysfunction, and pyroptotic cell death, ultimately accelerating the progression of non-alcoholic fatty liver disease (NAFLD) (101).